A KLH conjugated synthetic peptide selected from the N terminal region of human GADD45A.
Our Abpromise guarantee covers the use of ab76664 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||Use at an assay dependent concentration. PubMed: 23706118|
|WB||1/50 - 1/100. Predicted molecular weight: 18 kDa.|
Blocking/Dilution buffer: 5% NFDM/TBST.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"